TAKEAWAYS Revenue -- $6.9 million in the third quarter, an increase of 7.4% year over year, driven by higher service sales in ...

FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...